SCHEMBL13192501

SCHEMBL13192501

C/C=C\N/C=C\NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283850 0.82
SCHEMBL10981181 0.82
SCHEMBL283851 0.82
SCHEMBL7919434 0.78
SCHEMBL2568753 0.78
SCHEMBL386340 0.78
Ammonia Solution, Strong SCHEMBL5678834 0.74
Hydrochloric Acid SCHEMBL22575371 0.74
Hydrochloric Acid SCHEMBL22771774 0.74
SCHEMBL284306 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024008967-A1 LIPID NANOPARTICLES COMPRISING AN IMIDAZOLIUM-BASED CATIONIC LIPID POLYPLUS TRANSFECTION (FR) 2024-01-11 WO disclosed
WO-2021050964-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2021-03-18 WO disclosed
EP-2617752-B1 COMPOSITION USABLE AS THERMAL-LATENT POLYMERIZATION INITIATOR NIPPON CATALYTIC CHEM IND (JP) 2018-07-25 EP disclosed
WO-2010107605-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-09-23 WO disclosed